Overall Technical outlook

Price Summary

Mankind Pharma Limited's stock dived -2.57% today, reflecting an lacklustrending market day.
On 2026-07-01, Mankind Pharma Limited's shares started at 2555.9, peaked at 2570.8, bottomed out at 2475.1, and ended -2.57% lower at 2490.3, with 211207 shares traded.
The stock's highest price in the past 52 weeks is 2696.5, while its lowest price during the same period is 1927.4.

Technicals

Support and Resistance: The price currently sits at 2490.3, finding support at 2468.8 and resistance at 2468.8. These levels define a range for Mankind Pharma Limited where the price may move, with 2468.8 offering a base and 2468.8 limiting upward momentum.
MANKIND supportResistance 47ddef
Support/Resistance for MANKIND


Aroon: The AROON is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
MANKIND aroon 47ddef
Aroon chart for Mankind Pharma Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
MANKIND bbands 47ddef
Bolinger Bands chart for Mankind Pharma Limited


Parabolic SAR: The PSAR for MANKIND maintains a bullish outlook, establishing a crucial support level that may help maintain the current upward momentum. This strong support suggests that the market is poised to continue its upward trend, providing confidence in the ongoing bullish sentiment.
MANKIND psar 47ddef
Parabolic Stop and Reverse chart for Mankind Pharma Limited


Stochastic: The STOCHASTIC is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
MANKIND stoch 47ddef
Stochastic chart for Mankind Pharma Limited


Tripple Moving Agerage: The 20, 50, and 100 moving averages are currently aligned bearishly, indicating a downtrend. However, the slopes of the 20 and 50 SMAs are starting to waver, suggesting that this bearish momentum might be fading. This could be an early indication of a potential bullish reversal, as the market's current downward trend loses strength and prepares for a possible shift towards more positive price action.
MANKIND trippleSMA 47ddef
Tripple SMA chart for Mankind Pharma Limited


To accurately interpret a company's technical data, it is important to first examine its fundamentals. These include financial performance, management quality, and growth prospects. In addition, understanding the dynamics of the industry in which the company operates—such as competition, market trends, and regulatory factors—provides further insights. This combined analysis helps create a fuller picture, allowing for more precise conclusions to be drawn from the company's technical performance and stock behavior.